This provides some comfort that the use of DPP-4 inhibitors by patients is unlikely to confer additional heart risk from these drugs [35]
Both medications should be prescribed under medical supervision
For example, combination therapies involving linagliptin and alogliptin benzoate, both dipeptidyl peptidase-4 (DPP-4) inhibitors, were omitted as they primarily target the Protein Digestion and Absorption pathway, which was not part of the comorbidity network and thus did not contribute to the network-based impact analysis
Excess LDL exposure increases the cholesterol uptake and growth of triple negative as well as ER-negative breast cancer cells [60, 101] and HDL can increase the growth and migration of ER-positive cells [65, 70]
Multiple other causes should be considered including peripheral vascular disease, neuropathy, medication effects from other drugs (particularly diuretics, beta-agonists, and statins), hypothyroidism, pregnancy, and musculoskeletal conditions